Multifunctional peptide-assembled micelles for simultaneously reducing amyloid-β and reactive oxygen species

Area of Science:

• Neuroscience
• Biomedical Engineering
• Materials Science

Background:

• Alzheimer's disease (AD) is characterized by amyloid-beta (Aβ) plaques and oxidative stress from reactive oxygen species (ROS).
• Aβ and metal ion interactions generate ROS, accelerating AD progression.
• Simultaneously clearing Aβ and ROS is a novel therapeutic strategy for AD.

Purpose of the Study:

• To design multifunctional micelles (MPGLT) for simultaneous Aβ clearance and ROS scavenging in AD therapy.
• To investigate the therapeutic potential of MPGLT in an AD mouse model.

Main Methods:

• Development of polymer-grafted peptide micelles (MPGLT) incorporating three functional peptides: tk-GSH (ROS scavenger), LP (β-sheet breaker), and TK (autophagy activator).
• In vitro assessment of Aβ capture/degradation and ROS scavenging.
• In vivo evaluation in an AD mouse model, including blood-brain barrier penetration, Aβ plaque reduction, and ROS elimination.

Main Results:

• MPGLT effectively captured and degraded Aβ.
• The tk-GSH component efficiently scavenged intracellular ROS.
• MPGLT reduced Aβ and ROS cytotoxicity in vitro.
• In vivo studies demonstrated MPGLT's ability to cross the blood-brain barrier, decrease Aβ plaques, and eliminate ROS in an AD mouse model.

Conclusions:

• Multifunctional peptide micelles (MPGLT) offer a synergistic approach for simultaneously clearing Aβ and ROS.
• This strategy shows significant therapeutic potential for Alzheimer's disease.
• The findings provide novel insights for developing peptide micelle-based therapies for AD.